Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 12Breast 5CNS 3Thoracic 2Sarcoma 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Classical hematology 1

Conditions

Glioblastoma 2Neuroma, Acoustic 1Edema 1Brain Neoplasms 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Losartan × CNS × Clear all
NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Massachusetts General Hospital

Phase 2 Active not recruiting
30 enrolled
CNS

Neuroma, Acoustic

NCT03951142 2023-11-01

ImPRESS

Oslo University Hospital

Phase 2 Unknown
165 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT01805453 2020-05-08

ASTER

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
80 enrolled
CNS

Edema, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡